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ABSTRACT
Background Deaths directly linked to COVID-19 
infection may be misclassified, and the pandemic 
may have indirectly affected other causes of death. To 
overcome these measurement challenges, we estimate 
the impact of the COVID-19 pandemic on mortality, 
life expectancy and lifespan inequality from week 10 of 
2020, when the first COVID-19 death was registered, 
to week 47 ending 20 November 2020 in England and 
Wales through an analysis of excess mortality.
Methods We estimated age and sex- specific excess 
mortality risk and deaths above a baseline adjusted 
for seasonality with a systematic comparison of four 
different models using data from the Office for National 
Statistics. We additionally provide estimates of life 
expectancy at birth and lifespan inequality defined as the 
SD in age at death.
Results There have been 57 419 (95% prediction 
interval: 54 197, 60 752) excess deaths in the first 47 
weeks of 2020, 55% of which occurred in men. Excess 
deaths increased sharply with age and men experienced 
elevated risks of death in all age groups. Life expectancy 
at birth dropped 0.9 and 1.2 years for women and 
men relative to the 2019 levels, respectively. Lifespan 
inequality also fell over the same period by 5 months for 
both sexes.
Conclusion Quantifying excess deaths and their impact 
on life expectancy at birth provide a more comprehensive 
picture of the burden of COVID-19 on mortality. Whether 
mortality will return to—or even fall below—the 
baseline level remains to be seen as the pandemic 
continues to unfold and diverse interventions are put in 
place.
INTRODUCTION
Estimating the number of deaths caused by the 
COVID-19 pandemic is an important challenge.1 
Insufficient testing capacity for SARS- CoV-2, the 
causative pathogen of coronavirus disease, espe-
cially during the early phases of the pandemic, 
misclassification of causes of death and defini-
tional inconsistencies in counting COVID-19 
deaths across different sources make the true toll 
of COVID-19 infections hard to estimate.2 3 More-
over, interventions imposed during the pandemic 
may have indirectly affected other causes of death.4 
For example, both fear of COVID-19 and the 
overstretching of the healthcare system may have 
deterred care seeking for both chronic and acute 
conditions, potentially increasing mortality from 
other, non- COVID, causes.5 Similarly, restrictions 
might have decreased deaths from external causes 
such as road traffic accidents, or increased deaths 
from causes such as suicide.
To overcome these measurement challenges, 
an alternative approach to estimate the mortality 
burden of COVID-19 is to quantify the number of 
deaths during the pandemic compared with a base-
line level of what would have been expected if the 
pandemic had not occurred. This approach for esti-
mating excess all- cause mortality has been widely 
used to quantify the mortality toll of previous 
epidemics such as influenza6 or HIV7 and has 
also begun to be applied for COVID-19.1 8 Excess 
mortality may be quantified in different ways and 
the ‘excess numbers of deaths’' approach has been 
commonly used so far in England and Wales.4 8 9 
While this metric provides an important measure 
of the burden of the pandemic on a society, simply 
counting total excess deaths does not provide an 
understanding of the substantial variation by age 
and sex over time in elevated mortality risks.10 11 nor 
does it allow for a comparison of current mortality 
conditions with past conditions due to changes in 
population age structure over the period. Further-
more, excess deaths do not provide an under-
standing of the cumulative impact of the pandemic 
on summary indicators of population health such as 
life expectancy.
Life expectancy at birth is a commonly used 
age- standardised summary indicator of popula-
tion health that expresses the average number of 
years a newborn would be expected to live given 
the death rates in a particular period.12 While no 
individual would actually be expected to experience 
these death rates throughout their life, life expec-
tancy provides a snapshot of the mortality profile 
of a population in a given period. Additionally, life 
expectancy is a comparable indicator of population 
health that does not require the arbitrary choice of 
a standard population as done with reported stan-
dardised death rates. Furthermore, as life expec-
tancy is sensitive to the ages at which deaths occur 
and because it is comparable across time, it can shed 
additional light on the cumulative burden of a crisis 
such as COVID-19 on population health and enable 
comparisons with previous population health condi-
tions. Lifespan inequality is another complementary 
indicator of population health with implications 
for public health planning, which has increasingly 
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While life expectancy is a measure of average mortality, lifespan 
inequality focuses on a second dimension of mortality: the vari-
ation in length of life between individuals in a population. It is 
possible for two populations to have the same life expectancy 
(ie, average) with different levels of lifespan inequality because 
of the variation in the distribution of the ages of death. Thus, 
lifespan inequality provides a complementary perspective that 
reflects how unevenly population health improvements are 
shared within a population, which has important implications 
for health and social care planning. Trends over the 20th century 
from high- income countries, including England and Wales, 
show that as life expectancy and the modal age at death have 
increased, lifespan inequality has tended to decrease.16 Never-
theless, the age dynamics driving improvement in each indicator 
is different. Reducing mortality at any age increases life expec-
tancy. However, for lifespan inequality to decrease when life 
expectancy is increasing, more lives need to be saved at younger 
than older ages, usually below life expectancy.13 This compresses 
the distribution of deaths, making ages at death more similar.
We estimate all- cause excess deaths from week 10 (March 
2–8), the week in which the first death attributable to COVID-19 
was registered in England and Wales, to latest data that were 
available at the time of writing this article from week 47 of 
2020 (ending 20 November). Our work builds on existing esti-
mates and approaches in three ways. First, we provide estimates 
disaggregated by age and sex, to highlight variations in excess 
deaths during the pandemic in England and Wales. Second, we 
develop refined model- based counterfactual estimates of excess 
deaths that better account for exposures and seasonal mortality 
patterns. We also systematically assess the sensitivity of excess 
deaths to different model- based estimates. Third, we provide 
estimates of life expectancy and lifespan inequality during 
the first 47 weeks of 2020 and compare them with previous 
mortality trends. By considering all three measures together: 
excess deaths, life expectancy and lifespan inequality, this study 
presents a comprehensive assessment of the mortality impacts of 
the COVID-19 pandemic thus far.
METHODS
Data
We extracted all- cause death counts stratified by week of death 
registration and sex from 2010 to the week for which latest data 
were available (week 47 of 2020) from the Office for National 
Statistics (ONS) for England and Wales. While weekly mortality 
data are available by 5- year age groups for 2020, this level of 
disaggregation is not available for previous years. Therefore, we 
used six age- groups (0–14, 15–44, 45–64, 65–74, 75–84 and 
85- older years of age) for modelling weekly deaths to harmonise 
weekly death data across 2010–2020 and used the 5- year age 
intervals for calculating life expectancy and lifespan inequality 
estimates for 2020. We also obtained population estimates 
from ONS from 2010 to 201917 and population projections 
for 2020.18 As these projections represent the population at the 
mid- year point, we used standard interpolation techniques19 to 
estimate weekly mean population by sex and age groups over 
the study period to use them as offset in the modelling strategy. 
Yearly death counts by 5- year age groups were used to calcu-
late annual indicators20 such as life expectancy and lifespan 
inequality. All analyses use publicly available aggregated data. 
The population coverage of vital registration in England and 
Wales is complete. Between March and May 2020, 81.1% of all 
deaths and 86.5% of deaths involving COVID-19 were registered 
within 1 week of occurrence.21 Death registration in this period 
witnessed increased efficiency compared with trends noted in 
previous years due to changes implemented in the Coronavirus 
Act 2020.22 23 Based on trends from past years, 92% of deaths 
are registered within 1 month of occurrence. As the extent of 
bias caused by registration delays is not properly understood, we 
do not attempt to implement any correction factors to minimise 
risks of overcorrection and inflating our findings.
Excess mortality
We estimated the baseline number of deaths in the absence of 
COVID-19 by fitting four different models. First, we fitted 
generalised additive models assuming negative binomial and 
Poisson distributions of deaths during the period of study.24 
These models include a log- linear mortality trend by sex and 
age, smoothed effects for age and seasonality and an interac-
tion between age and seasonality (see online supplemental 
section 1). The smoothed effects are stratified by sex. Third, we 
fitted a generalised Poisson linear model adjusted for year- to- 
year seasonality,25 also known as extended Serfling model26 (see 
online supplemental section 1). These previous models included 
indicator variables for systematic lags in death registration 
observed in weeks coinciding with holidays (weeks 1, 52 and 
22 (bank holidays)). Finally, for our fourth model, we created a 
baseline by averaging the death rates observed in each week of 
the years 2015–2019 (see online supplemental figures 1 and 2).
We fitted the models to the weekly death counts from 4 
January 2010 to the week starting on 2 March 2020. This base-
line was then projected forward until 20 November 2020 (week 
47). Excess mortality is then defined as the observed weekly 
death count minus the baseline, summed across the pandemic 
period from 2 March 2020 (week 10) to 20 November 2020 
(week 47). From this baseline, 95% predictive intervals were 
constructed by sampling death counts from negative binomial 
and Poisson distributions depending on the model’s underlying 
distribution.
We report excess death estimates from the negative binomial 
model in the main text but estimates comparing the different 
approaches are provided in the online supplemental materials. 
This choice is based on out- of- sample predictive performance on 
past non- COVID weekly death counts.
Demographic methods
Life expectancy and lifespan inequality by sex were estimated 
using the yearly death counts and population estimates for the 
years preceding 2020 using standard demographic techniques,12 
from which 95% predictive intervals were generated.27 For the 
47 weeks of 2020 for which data were available, death counts 
were aggregated over age groups and death rates were calculated 
using a proportionally adjusted mid- year population estimate.
Code and data availability
All analyses were carried out using R software.28 All analysis 
scripts and data are available in a public repository and will be 
updated as more data become available.29
RESULTS
Estimates of excess deaths
The first death attributable to COVID-19 in England and Wales 
was registered in the week starting on 2 March 2020 (week 10). 
From that week until the end of week 47 on 20 November 2020, 
there were 436 102 registered deaths, from which an estimated 
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baseline (see figure 1). This estimate represents a 15.1% (14.2, 
16.2) increase in deaths compared with the expected level.
Death rates during the pandemic were consistently higher 
among men in all groups compared with women (see online 
supplemental figure 3). Male excess deaths accounted for 55.4% 
(31 791 deaths) of total excess deaths, compared with 44.6% 
(25 629 deaths) among women over the same period, despite the 
fact that women make up a larger fraction of the older popula-
tion. Between 2 March and 20 November, male deaths exceeded 
the expectation by 16.8% (15.4, 18.0) and female death counts 
by 13.6% (12.2, 14.9). Cumulative excess deaths at the end of 
the first wave (week 26 ending in June 29) were 53 937 (95% 
prediction interval: 53 092, 54 746) followed by no excess 
mortality over the summer months, before an uptick that started 
in October 2020 when a second wave emerged and excess deaths 
began to rise again.
Disaggregating by age, we estimate no excess deaths among 
those younger than 15 years. The 15–44- year- old age group 
accounted for 652 (395, 903) excess deaths (6.2% (3.6, 8.7) 
above the expected level). For older age groups, excess deaths 
rose sharply (see figure 2). The toll of the pandemic resulted 
in 7859 (7065, 8645) and 9835 (8814, 10 833) excess deaths 
among people between 45–64 and 64–74 years of age, respec-
tively. These numbers are 17.6% (15.6, 19.7) and 16.0% (14.1, 
17.9) above the baseline. The largest numbers of lives lost were 
estimated among the groups 75–85 and 85 and older, with 
17.2% (15.3, 19.2) and 13.7% (11.9, 15.4) more deaths than 
expected. Among the former, 18 591 (16 845, 20 435), excess 
deaths were estimated, while among the oldest age group, there 
were 20 641 (18 271, 22 916) deaths above the baseline. Note 
the larger number of female excess deaths in the 85+ age group 
is due to there being 1.6 times more women in this age group 
compared with men. After a peak in excess deaths by June 2020, 
the 85+ age group saw somewhat lower than baseline mortality 
over the summer months, before an increasing trend in excess 
deaths emerged again in the second wave from October 2020. In 
contrast, for all other age groups, mortality remained at baseline 
over the summer months.
Estimates of life expectancy and lifespan inequality
Female life expectancy at birth increased from 81.4 (81.3, 81.4) 
years in 2005 to 83.5 (83.5, 83.6) years in 2019 in England and 
Wales (see figure 3). Similarly, male life expectancy increased 
from 77.1 (77.1, 77.2) to 79.9 (79.8, 79.9) years in the same 
period. Using data from the first 47 weeks of 2020 yields an 
estimated life expectancy at birth of 82.6 (82.5, 82.6) and 78.7 
(78.6, 78.7) for women and men, respectively, a reduction of 0.9 
years for women and 1.2 years for men.
From 2005 to 2019, lifespan inequality declined slowly 
from 13.8 (13.7, 13.9) to 13.5 (13.4, 13.6) years for women 
and from 15.0 (15.0, 15.1) to 14.7 (14.6, 14.7) years for men 
(see figure 3). Over the first 47 weeks of 2020, we estimate that 
lifespan inequality fell sharply to 13.1 (13.0, 13.1) and 14.2 
(14.2, 14.3) years for women and men, respectively, corre-
sponding to a reduction of nearly 5 months for both sexes.
Sensitivity analysis
We performed several sensitivity analyses. First, we refitted the 
seasonal baseline without including the first 9 weeks of 2020. 
This adjustment did not have major effects on our estimates, and 
by taking the first 9 weeks into account, we aligned our predic-
tions with the observed trend at the beginning of the year. Our 
four models produce central estimates of the number of excess 
deaths between 49 056 and 57 419 depending on the choice of 
the model and its assumptions, but do not substantively affect 
the pattern of our results. We note that excess deaths derived 
from the baselines estimated from both the generalised additive 
models and generalised linear models indicated a higher magni-
tude of excess deaths than those using average mortality rates 
from the preceding 5 years as the baseline. For full details, see 
online supplemental tables 1 and 2. In addition, we also esti-
mated life expectancy using a piecewise constant hazard model 
and the results did not change.
DISCUSSION
Excess deaths during the first 47 weeks of the year 2020 shed 
light on the cumulative burden of the COVID-19 pandemic 
in England and Wales. While several European countries have 
experienced substantially increased mortality over the course of 
the pandemic, data at hand suggest that England and Wales are 
among the worst performers in terms of excess deaths, especially 
in the working- age group 15–64.30 We estimated 57 419 (54 197, 
60 752) premature deaths due to the pandemic. Our estimate 
is based on a systematic comparison of different approaches to 
estimating a mortality baseline from which excess is derived and 
Figure 1 Cumulative excess deaths in England and Wales through 
the COVID-19 pandemic weeks 10–47 of 2020 by sex. Shaded areas 
represent 95% prediction intervals. Excess deaths are defined as the 
total observed deaths subtracting the estimated baseline death count.
Figure 2 Cumulative excess deaths in England and Wales through 
the COVID-19 pandemic weeks 10–47 of 2020 by sex and age groups. 
Shaded areas represent 95% prediction intervals. Excess deaths are 
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relies on a refined model that accounts for changes in population 
ageing and seasonality. The toll of the pandemic had unequal 
impacts by age and sex in Europe and other regions.31–33 Simi-
larly for England and Wales and consistent with other work,8 
we found that excess mortality varied between sexes, with males 
accounting for 55% of excess deaths. Excess deaths increased 
sharply over age and male deaths were estimated to exceed 
women in all age groups, with the exception of those above age 
85. This is explained by the population composition of England 
and Wales where more women survive to older ages. Accounting 
for this compositional effect, death rates during 2020 were 
higher among men in all ages groups (see online supplemental 
figure 3).
According to the ONS, between 1 March and 30 June 2020, 
there were 50 335 deaths involving COVID-19, 46 736 (93%) 
of which assigned COVID-19 as the underlying cause of death 
based on information noted on the death certificate.21 A sizeable 
fraction of our estimate for excess deaths over the first wave 
of the pandemic is thus likely to be directly linked to COVID-
19. Based on preliminary cause of death analysis of other (non- 
COVID) causes by the ONS, deaths occurring from Alzheimer 
disease and dementia, ischaemic heart disease, cerebrovascular 
diseases, influenza and pneumonia and ‘symptoms signs and ill- 
defined conditions’ category were all higher between March and 
May 2020.22 Together Alzheimer and ‘symptom signs and ill- 
defined conditions’ experienced the largest increases in magni-
tudes compared with previous years, and deaths occurring from 
asthma and diabetes at home also increased.22 These prelimi-
nary cause- of- death patterns suggest that a significant fraction 
of the unexplained excess mortality over the first wave of the 
pandemic may also be attributable to undiagnosed COVID-19. 
As more detailed cause- of- death data become available over the 
coming months, future research should seek to develop methods 
to disentangle excess deaths attributable to COVID-19 versus 
those arising indirectly due to effects such as reduced care for 
other conditions.
For the latter half of 2020, in the period from 15 June to the 
end of August (weeks 25–36), our estimates showed no excess 
mortality in most weeks for those under 85 before the emergence 
of a second wave of excess mortality from October. The lower 
than baseline mortality observed in the summer months of the 
85+ age group suggests potential mortality displacement effects, 
that is, that some deaths were brought forward in this age group 
due to the pandemic, although the numbers far from compen-
sated for first wave deaths even at these oldest ages. However, 
no similar signs of mortality displacement due to lower than 
baseline mortality were visible for the other age groups over the 
summer. As these estimates are based on deaths registered so far, 
it is too early to clarify the contributions of mortality displace-
ment to excess mortality observed during the pandemic and its 
impacts on postcrisis mortality levels.
Life expectancy in England and Wales had been steadily 
improving for 50 years before stagnating in the past decade.34 35 
We have provided estimates of life expectancy for 2019 and 
2020 based on mortality data until week 47, which show that 
life expectancy dropped a staggering 0.9 and 1.2 years for 
women and men, respectively, between these years. Moreover, 
our estimates for life expectancy fall 0.7 and 1.1 years below 
the official projected life expectancy in 2020 for women and 
men,36 respectively. To put this into perspective, male and female 
life expectancy regressed to the levels of 2010. It is likely that 
our estimates of excess deaths and life expectancy losses until 
this period are underestimated, as these estimates are based on 
deaths registered so far, a small fraction of which may have expe-
rienced registration delays.21 Our estimates also do not account 
for excess mortality that occurred during weeks 48-52 of 2020, 
which are likely to further reduce life expectancy estimates for 
the full year. Recent evidence suggests that reversals and stagna-
tion in life expectancy among developed countries are usually 
a result of mid- life mortality crises.35 In contrast, life expec-
tancy losses during the pandemic have come about from sharp 
increases in older age mortality in both sexes.
Figure 3 Life expectancy and lifespan inequality (SD of ages at death) estimates for the periods 2001–2019, and for 2020 considering the first 47 
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Historically, life expectancy increases have been accompanied 
by reductions in lifespan inequality due to mortality improve-
ments at younger ages, although more recent studies have found 
that life expectancy improvements can occur even without 
accompanying reductions in lifespan inequality.13 Our results 
strikingly show a third, previously undocumented pattern of life 
expectancy and lifespan inequality change, with both decreasing 
concurrently due to the unique nature of the mortality stress 
triggered by the COVID-19 pandemic. In contrast with previous 
influenza pandemics such as the 1918–1920 Spanish influenza 
that primarily affected the young,37 or the 1957 pandemic that 
affected both the young and old,38 the mortality impact of the 
COVID-19 pandemic has primarily affected older age groups. 
Within a broader context of population health in which mortality 
is now largely concentrated at older ages, the elevated excess 
death rates at older age groups observed during the COVID-19 
pandemic so far has reduced life expectancy. However, the 
disproportionate shift in the distribution of ages at death to 
older age groups made ages at death more similar, thereby 
reducing variation but at the expense of increasing overall 
average mortality. As a result of these dynamics, life expectancy 
and lifespan inequality moved in the same direction.
Looking forward, it is unclear if life expectancy will return 
to baseline levels rapidly, and even if/when it recovers, how 
mortality will be different. The prospect of vaccination being 
likely in the near future suggests a potential for the rapid 
recovery of life expectancy, although this will depend on the 
rollout speed, coverage and efficacy of the vaccine.39 In contrast, 
the combination of potential scarring effects of COVID-19, such 
as the long- term consequences of the disease on individuals' 
health,40 the implications of lockdown and non- pharmaceutical 
interventions on behaviours and mental health,41 cancer treat-
ment delay associated with increased mortality42 and the unequal 
impact of COVID-19 across subgroups by age, sex, ethnicity 
socioeconomic status and regions,43 44 could create an unseen 
mortality profile that maintains life expectancy at lower levels 
beyond the short term into the medium term.
Twitter Jose Manuel Aburto @jm_aburto, Ridhi Kashyap @ridhikash07, Colin 
Angus @victimofmaths, Melinda C Mills @melindacmills and Jennifer Beam Dowd @
drjenndowd
Contributors JMA, RK, JS and JBD contributed to the design of the study. JMA, 
RK and CA drafted the manuscript. JS and JMA performed the statistical analysis. 
All authors contributed to interpretation of data, revised the article critically for 
important intellectual content, and approved the final version of the manuscript. 
JMA and RK, the corresponding authors, attest that all listed authors meet 
authorship criteria and that no others meeting the criteria have been omitted.
Funding JMA and RK acknowledge support from the British Academy Newton 
International Fellowship; JMA and JS acknowledge support from the Rockwool 
Foundation grant on Excess Deaths; JMA, RK, JBD and MCM were supported by 
Leverhulme Trust, John Fell Fund and H2020 European Research Council Advanced 
Grant 835 079. CA was supported by the SIPHER Consortium (https:// sipher. ac. uk/), 
part of the UK Prevention Research Partnership (MR/S037578/1), an initiative funded 
by UK Research and Innovation Councils, the Department of Health and Social 
Care (England) and the UK devolved administrations, and leading health research 
charities. Weblink: https:// ukprp. org/
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available in a public, open access 
repository. All data and code used for this article is available in an open access 
repository (https:// github. com/ OxfordDemSci/ Excess- Deaths). The repository includes 
aggregated death counts used in this paper retrieved from the ONS form https://
www. ons. gov. uk/ peop lepo pula tion andc ommunity/ birt hsde aths andm arriages/ deaths/ 
datasets/ week lypr ovis iona lfig ures onde aths regi ster edin engl anda ndwales. The data 
and code are accessible for public use.
Supplemental material This content has been supplied by the author(s). It 
has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have 
been peer- reviewed. Any opinions or recommendations discussed are solely those 
of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and 
responsibility arising from any reliance placed on the content. Where the content 
includes any translated material, BMJ does not warrant the accuracy and reliability 
of the translations (including but not limited to local regulations, clinical guidelines, 
terminology, drug names and drug dosages), and is not responsible for any error 
and/or omissions arising from translation and adaptation or otherwise.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
ORCID iDs
Jose Manuel Aburto http:// orcid. org/ 0000- 0002- 2926- 6879
Ridhi Kashyap http:// orcid. org/ 0000- 0003- 0615- 2868
Jonas Schöley http:// orcid. org/ 0000- 0002- 3340- 8518
Colin Angus http:// orcid. org/ 0000- 0003- 0529- 4135
John Ermisch http:// orcid. org/ 0000- 0002- 3633- 5246
Melinda C Mills http:// orcid. org/ 0000- 0003- 1704- 0001
Jennifer Beam Dowd http:// orcid. org/ 0000- 0003- 2006- 5656
REFERENCES
 1 Weinberger DM, Chen J, Cohen T, et al. Estimation of excess deaths associated with 
the COVID-19 pandemic in the United States, March to may 2020. JAMA Intern Med 
2020;180:1336–44.
 2 Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid 
dissemination of novel coronavirus (SARS- CoV-2). Science 2020;368:489–93.
 3 ONS. The different uses of figures on deaths related to COVID-19 published by DHSC 
and the ONS - Office for National Statistics. Available: https://www. ons. gov. uk/ news/ 
What is already known on this topic
 ► COVID-19- related deaths may be misclassified, thereby 
inaccurately estimating the full impact of the pandemic on 
mortality. The pandemic may also have indirect effects on 
other causes due to changed behaviours as well as the social 
and economic consequences resulting from its management. 
Excess mortality, the difference between observed deaths 
and what would have been expected in the absence of the 
pandemic, is a useful metric to quantify the overall impact 
of the pandemic on mortality and population health. Life 
expectancy at birth and lifespan inequality assess the 
cumulative impact of the pandemic on population health.
What this study adds
 ► We examine death registration data from the Office for 
National Statistics from 2010 to week 47 (ending on 20 
November) in 2020 to quantify the impact of the COVID-19 
pandemic on mortality in England and Wales thus far. We 
estimate excess mortality risk by age and sex and quantify 
the impact of excess mortality risk on excess deaths, life 
expectancy and lifespan inequality. During weeks 10 to 47 of 
2020, elevated mortality rates resulted in 57 419 additional 
deaths compared with baseline mortality. Life expectancy 
at birth for women and men over the 47 weeks of 2020 
was 82.6 and 78.7 years, with 0.9 and 1.2 years of life lost 
relative to the year 2019. Lifespan inequality, a measure of 
the spread or variation in ages at death, declined due to the 
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